EVAX: Evaxion Biotech A/S - ADR Company Profile & Statistics

About

Evaxion Biotech A/S is a clinical-stage biotechnology company. It involved in the development of AI-driven immunotherapies for patients with cancer and infectious diseases. Evaxion Biotech A/S is based in COPENHAGEN, Denmark.

Info & Links

CEO

Christian Kanstrup

Headquarters

Dr. Neergaards Vej 5F
Hoersholm, G7 2970, DENMARK

Auditor

EY Godkendt Revisionspartnerselskab

Share holders

Employees

Evaxion Biotech A/S - ADR Statistics

Valuation Measures

Market Capitalization²

5.17M

Enterprise Value

589.60K

Enterprise Value/EBITDA(ttm)

-0.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.03

Price to Book(mrq)

85.93

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

-347.83%

Profit Margin(ttm)

-1006.17%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-71.00%

Return on Assets(ttm)

-79.40%

Income Statement

Revenue(ttm)

3.17M

Revenue Per Share(ttm)

Gross Profit(ttm)

3.17M

EBITDA(ttm)³

-4.58M

Net Income Available to Common(ttm)

-8.13M

Diluted EPS(ttm)

-0.29

Share Statistics

Beta (5Y Monthly)

-0.39

52-Week Change

-89.27%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

3.42M

% Held by Insiders

41.64%

% Held by Institutions

11.04%

Balance Sheet

Total Cash(mrq)

4.58M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

Quick Ratio(mrq)

2.80%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EVAX

Evaxion Biotech A/S - ADR

Evaxion Biotech A/S - ADR Profile